Biosafety treaty deal

Delegates from 140 countries on Saturday approved a compromise protocol on biosafety intended to govern the international transport of living modified organisms (LMOs).

As approved at the Montreal meeting, the so-called Cartegena Protocol on Biosafety excludes pharmaceutical products from its oversight and does not mandate segregated shipping of LMO products. But it validates use of the precautionary principle to ban imports of LMOs and includes provisions for labeling of commodity shipments.

The agreement, which will become part of the Convention on Biological Diversity (CBD), will go into

Read the full 857 word article

How to gain access

Continue reading with a
two-week free trial.